Debra Ainge
Chief Executive Officer at Iethico Ltd.
Network origin in Debra Ainge first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Iethico Ltd. is a British company that aims to reduce the impact of medicine shortages and provide faster access to medicine. The company is based in Coventry, UK. The company links pharmacists to suppliers to bridge the gap between medicine access and supply. The company delivers insights to minimize medicine shortage impact through AI. The company was founded in 2021 by Renee Kalia, Claudio Zurzica. Debra Ainge has been the CEO of the company since 2020.
2
| Holding Company | Information Technology Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Debra Ainge via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Corporate Officer/Principal | |
University of Surrey | College/University | Undergraduate Degree | |
Henley Management College | College/University | Masters Business Admin | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
DC Biosciences Ltd.
DC Biosciences Ltd. BiotechnologyHealth Technology DC Biosciences Ltd. provides bioreagents and life science services. The firm’s products include cell extracts, fresh primary mammalian cells, recombinant proteins, steroid beads, fluorescent cell markers, and SILAC reagents. Its services include custom antibody service, custom antibody service, DNA cloning services, gene synthesis service, and protein expression, gene to stable cell line, mass spectrometry, quantitative proteomics, and peptide synthesis. The company was founded by Angus Lamond and Paul Ajuh in June 2006 and is headquartered in Dundee, the United Kingdom. | Biotechnology | Chairman | |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Operating Officer | |
University of Birmingham Enterprise Ltd.
University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise Ltd (University of Birmingham Enterprise) is a venture capital subsidiary of University of Birmingham founded in 2008. The firm is headquartered in Birmingham, United Kingdom. | Investment Managers | Private Equity Investor | |
Questrax Ltd. | Corporate Officer/Principal | ||
The Institute of Directors (United Kingdom)
The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Scottish Ballet
Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Movies/Entertainment | Director/Board Member | |
Beecham Pharmaceuticals (UK) | Corporate Officer/Principal | ||
D3tex Ltd. | Director/Board Member | ||
CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Secretary | |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Director/Board Member | |
BQR Consulting Ltd. | Director/Board Member |
Statistics
International
United Kingdom | 21 |
United States | 3 |
Netherlands | 2 |
Canada | 2 |
Sectoral
Health Technology | 11 |
Commercial Services | 5 |
Consumer Services | 5 |
Process Industries | 2 |
Finance | 2 |
Operational
Director/Board Member | 12 |
Corporate Officer/Principal | 8 |
Founder | 4 |
Chief Executive Officer | 3 |
Chairman | 3 |
Most connected contacts
- Stock Market
- Insiders
- Debra Ainge
- Company connections